Free Trial

CytoDyn (CYDY) Short Interest Ratio & Short Volume

CytoDyn logo
$0.12
0.00 (0.00%)
(As of 11/4/2024 ET)

CytoDyn Short Interest Data

CytoDyn (CYDY) has a short interest of 13.18 million shares. This marks a 0.35% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.1, indicating that it would take 2.1 days of the average trading volume of 2.60 million shares to cover all short positions.

Current Short Interest
13,179,400 shares
Previous Short Interest
13,133,500 shares
Change Vs. Previous Month
+0.35%
Dollar Volume Sold Short
$1.91 million
Short Interest Ratio
2.1 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
1,219,350,000 shares
Percentage of Shares Shorted
1.08%
Today's Trading Volume
4,994,302 shares
Average Trading Volume
2,597,823 shares
Today's Volume Vs. Average
192%
Short Selling CytoDyn?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for CytoDyn and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CYDY Short Interest Over Time

CYDY Days to Cover Over Time

CYDY Percentage of Float Shorted Over Time

CytoDyn Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/202413,179,400 shares $1.91 million +0.4%N/A2.1 $0.14
9/30/202413,133,500 shares $2.08 million +1.2%N/A3.4 $0.16
9/15/202412,982,100 shares $1.95 million +20.1%N/A2.6 $0.15
8/31/202410,806,600 shares $1.62 million +0.1%N/A3.4 $0.15
8/15/202410,797,300 shares $1.26 million +25.3%N/A1.6 $0.12
7/31/20248,617,700 shares $1.23 million +7.4%N/A3.1 $0.14
7/15/20248,024,100 shares $1.13 million +13.5%N/A2.2 $0.14
6/30/20247,070,900 shares $982,855.10 +0.1%N/A1.8 $0.14
6/15/20247,062,000 shares $947,014.20 -12.4%N/A0.8 $0.13
5/31/20248,060,300 shares $1.27 million +72.7%N/A0.8 $0.16
5/15/20244,666,400 shares $769,956.00 +0.5%N/A2.9 $0.17
4/30/20244,643,700 shares $650,118.00 -1.4%N/A2.8 $0.14
4/15/20244,711,300 shares $683,138.50 +0.7%N/A1.5 $0.15
3/31/20244,680,600 shares $764,107.95 -8.4%N/A1.6 $0.16
3/15/20245,107,100 shares $855,439.25 -1.0%N/A0.7 $0.17
2/29/20245,159,800 shares $1.33 million +9.2%N/A0.7 $0.26
2/15/20244,724,300 shares $798,595.67 -25.2%N/A0.8 $0.17
1/15/202410,691,100 shares $2.24 million -1.9%N/A3.1 $0.21
12/31/202310,893,600 shares $2.12 million +0.3%N/A1.8 $0.20
12/15/202310,863,000 shares $3.07 million -16.2%N/A1.2 $0.28
11/30/202312,960,200 shares $2.22 million 0.0%N/A2.6 $0.17
11/15/202312,965,900 shares $2.20 million -0.9%N/A6.7 $0.17
10/31/202313,087,700 shares $2.05 million +0.2%N/A5 $0.16
10/15/202313,058,200 shares $2.25 million -11.3%N/A7.5 $0.17
9/30/202314,723,600 shares $2.73 million -0.4%N/A8.3 $0.19
9/15/202314,785,400 shares $2.81 million +0.1%N/A9.2 $0.19
8/31/202314,770,500 shares $3.12 million -8.1%N/A8.6 $0.21
8/15/202316,067,600 shares $3.58 million -40.0%N/A2.2 $0.22
7/31/202326,765,000 shares $5.59 million +0.3%N/A7.8 $0.21
7/15/202326,695,600 shares $6.96 million -0.1%N/A10.5 $0.26
6/30/202326,722,500 shares $7.22 million -0.8%N/A11.1 $0.27
6/15/202326,948,200 shares $6.79 million -0.2%N/A9.9 $0.25
5/31/202327,009,000 shares $7.07 million -3.3%N/A14.2 $0.26
5/15/202327,921,000 shares $7.40 million +1.7%N/A13.9 $0.27
4/30/202327,460,800 shares $8.04 million -1.8%N/A18.5 $0.29
4/15/202327,965,300 shares $8.45 million +3.2%N/A6.7 $0.30
3/31/202327,096,500 shares $9.75 million +1.4%N/A11.2 $0.36
3/15/202326,726,800 shares $10.00 million +2.4%N/A5.6 $0.37
2/28/202326,113,800 shares $8.38 million +2.7%N/A7.2 $0.32
2/15/202325,428,900 shares $7.08 million -2.7%N/A6.8 $0.28
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

1/31/202326,140,000 shares $6.88 million -1.5%N/A6.9 $0.26
1/15/202326,528,000 shares $6.63 million -4.1%N/A6.7 $0.25
12/30/202227,656,900 shares $6.22 million -11.7%N/A2.7 $0.23
12/15/202231,304,500 shares $10.02 million -4.6%N/A10.7 $0.32
11/30/202232,811,200 shares $11.81 million -3.3%N/A13.5 $0.36
11/15/202233,929,800 shares $13.40 million -5.0%N/A16.1 $0.40
10/31/202235,699,900 shares $12.25 million -5.1%N/A17.8 $0.34
10/15/202237,621,300 shares $16.55 million -5.9%N/A16.9 $0.44
9/30/202239,993,600 shares $16.60 million +0.7%N/A11.8 $0.42
9/15/202239,705,000 shares $24.02 million -2.1%N/A23.3 $0.61
8/31/202240,549,900 shares $21.15 million -8.8%N/A11.2 $0.52
8/15/202244,456,900 shares $36.79 million -11.7%N/A4.8 $0.83
7/31/202250,345,200 shares $38.77 million -3.5%N/A5.8 $0.77
7/15/202252,176,600 shares $22.95 million -2.1%N/A13.2 $0.44
6/30/202253,281,600 shares $22.37 million +2.4%N/A32.8 $0.42
6/15/202252,028,700 shares $20.65 million +4.6%N/A12.6 $0.40
5/31/202249,725,000 shares $15.96 million +6.3%N/A19.8 $0.32
5/15/202246,788,400 shares $15.91 million +1.6%N/A16.1 $0.34
4/30/202246,043,000 shares $14.69 million +15.1%N/A7.5 $0.32
4/15/202239,997,200 shares $10.60 million -10.4%N/A7.2 $0.27
3/31/202244,660,400 shares $16.41 million +1.0%N/A6.9 $0.37
3/15/202244,227,800 shares $17.03 million +1.1%N/A14 $0.39
2/28/202243,739,200 shares $22.39 million +3.7%N/A10 $0.51
2/15/202242,170,100 shares $24.42 million +0.5%N/A9.9 $0.58
1/31/202241,945,600 shares $22.23 million +4.6%N/A5.9 $0.53
1/15/202240,088,600 shares $27.86 million +25.5%N/A3 $0.70
12/31/202131,937,600 shares $31.58 million -1.4%N/A6.1 $0.99
12/15/202132,391,100 shares $33.52 million +5.5%N/A6.2 $1.04
11/30/202130,702,100 shares $38.38 million +0.6%N/A8.1 $1.25
11/15/202130,529,000 shares $37.70 million -7.0%N/A5.1 $1.24
10/29/202132,828,700 shares $41.04 million -7.2%N/A6.6 $1.25
10/15/202135,369,200 shares $50.22 million -9.8%N/A8.5 $1.42
9/30/202139,207,900 shares $77.63 million +2.2%N/A7.1 $1.98
9/15/202138,362,800 shares $58.50 million +2.4%N/A9.1 $1.53
8/31/202137,467,600 shares $51.71 million +2.4%N/A11.4 $1.38
8/13/202136,577,500 shares $53.95 million +1.4%N/A6.9 $1.48
7/30/202136,063,100 shares $60.95 million +2.9%N/A8.7 $1.69
7/15/202135,060,100 shares $47.93 million -2.0%N/A8.5 $1.37
6/30/202135,769,200 shares $60.81 million -4.2%N/A9.5 $1.70
6/15/202137,327,400 shares $66.44 million -4.8%N/A8.3 $1.78
5/28/202139,220,400 shares $74.52 million +4.7%N/A4.8 $1.90
5/14/202137,454,600 shares $98.13 million +0.1%N/A10 $2.62
4/30/202137,406,300 shares $104.36 million -1.4%N/A12.5 $2.79
4/15/202137,949,100 shares $108.15 million +7.3%N/A5 $2.85
3/31/202135,355,800 shares $99.70 million +11.3%N/A9.5 $2.82
3/15/202131,756,800 shares $72.61 million +38.8%N/A2.2 $2.29
2/26/202122,887,200 shares $108.03 million +5.9%N/A3.3 $4.72
2/12/202121,610,000 shares $119.72 million -21.8%N/A2.2 $5.54
1/29/202127,620,400 shares $140.86 million -8.5%N/A5.2 $5.10
1/15/202127,043,500 shares $142.95 million +0.9%N/A3.9 $5.29
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

12/31/202028,551,500 shares $141.47 million +5.6%N/A1.7 $4.96
12/15/202027,043,500 shares $88.97 million +0.9%N/A3.9 $3.29
11/30/202026,802,300 shares $71.29 million -0.1%N/A8.5 $2.66
11/15/202026,829,000 shares $66.54 million +0.5%N/A4.1 $2.48
10/30/202026,696,700 shares $63.81 million +9.7%N/A4.7 $2.39
10/15/202024,327,000 shares $69.58 million +4.2%N/A4.6 $2.86
9/30/202023,357,800 shares $68.20 million -1.3%N/A5.4 $2.92
9/15/202023,659,300 shares $96.77 million -10.8%N/A3.3 $4.09
8/31/202026,536,800 shares $89.16 million +42.2%N/A2.3 $3.36
8/14/202018,666,200 shares $70.18 million +41.0%N/A2.3 $3.76
7/31/202013,240,400 shares $65.86 million +38.2%N/A1.2 $4.97
7/15/20209,577,900 shares $46.45 million -6.6%N/A0.5 $4.85
6/30/202010,252,400 shares $89.91 million +11.1%N/A0.7 $8.77
6/15/20209,230,700 shares $28.52 million -6.4%N/A1.9 $3.09
5/29/20209,858,200 shares $27.80 million +3.4%N/A1.5 $2.82
5/15/20209,536,700 shares $28.61 million +10.3%N/A0.9 $3.00
4/30/20208,650,000 shares $28.07 million +6.5%N/A0.7 $3.25
4/15/20208,119,200 shares $20.38 million +11.4%N/A0.4 $2.51
3/31/20207,287,900 shares $23.18 million +34.0%N/A1.3 $3.18
3/13/20205,440,900 shares $15.67 million -10.8%N/A1.4 $2.88
2/28/20206,100,100 shares $6.10 million -3.3%N/A1.4 $1.00
2/14/20206,311,200 shares $6.50 million +15.8%N/A0.5 $1.03
1/31/20205,451,900 shares $5.94 million +49.5%N/A1.2 $1.09
1/15/20203,647,100 shares $4.38 million +34.1%N/A0.7 $1.20
12/31/20192,720,300 shares $2.97 million +2,191.7%N/A0.4 $1.09

CYDY Short Interest - Frequently Asked Questions

What is CytoDyn's current short interest?

Short interest is the volume of CytoDyn shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 13,179,400 shares of CYDY short. Learn More on CytoDyn's current short interest.

What is a good short interest ratio for CytoDyn?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CYDY shares currently have a short interest ratio of 2.0. Learn More on CytoDyn's short interest ratio.

Is CytoDyn's short interest increasing or decreasing?

CytoDyn saw a increase in short interest in October. As of October 15th, there was short interest totaling 13,179,400 shares, an increase of 0.3% from the previous total of 13,133,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does CytoDyn's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to CytoDyn: Exscientia plc (2.73%), ORIC Pharmaceuticals, Inc. (17.01%), Mereo BioPharma Group plc (3.68%), Nuvation Bio Inc. (4.39%), Korro Bio, Inc. (4.63%), Neurogene Inc. (9.09%), Q32 Bio Inc. (15.93%), Corvus Pharmaceuticals, Inc. (3.90%), Elite Pharmaceuticals, Inc. (0.19%), Silence Therapeutics plc (1.12%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short CytoDyn stock?

Short selling CYDY is an investing strategy that aims to generate trading profit from CytoDyn as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against CytoDyn?

A short squeeze for CytoDyn occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CYDY, which in turn drives the price of the stock up even further.

How often is CytoDyn's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CYDY, twice per month. The most recent reporting period available is October, 15 2024.




This page (OTCMKTS:CYDY) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners